6-154010744-GC-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_001145279.4(OPRM1):c.-271delC variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as drug response (no stars).
Frequency
Genomes: not found (cov: 32)
Consequence
OPRM1
NM_001145279.4 5_prime_UTR
NM_001145279.4 5_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.303
Genes affected
OPRM1 (HGNC:8156): (opioid receptor mu 1) This gene encodes one of at least three opioid receptors in humans; the mu opioid receptor (MOR). The MOR is the principal target of endogenous opioid peptides and opioid analgesic agents such as beta-endorphin and enkephalins. The MOR also has an important role in dependence to other drugs of abuse, such as nicotine, cocaine, and alcohol via its modulation of the dopamine system. The NM_001008503.2:c.118A>G allele has been associated with opioid and alcohol addiction and variations in pain sensitivity but evidence for it having a causal role is conflicting. Multiple transcript variants encoding different isoforms have been found for this gene. Though the canonical MOR belongs to the superfamily of 7-transmembrane-spanning G-protein-coupled receptors some isoforms of this gene have only 6 transmembrane domains. [provided by RefSeq, Oct 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OPRM1 | NM_001145279.4 | c.-271delC | 5_prime_UTR_variant | 1/6 | NP_001138751.1 | |||
OPRM1 | NM_001145280.4 | c.-281delC | 5_prime_UTR_variant | 1/4 | NP_001138752.1 | |||
OPRM1 | NM_001145281.3 | c.47+189delC | intron_variant | NP_001138753.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OPRM1 | ENST00000434900 | c.-271delC | 5_prime_UTR_variant | 1/6 | 1 | ENSP00000394624.2 | ||||
OPRM1 | ENST00000520708.5 | c.-281delC | 5_prime_UTR_variant | 1/4 | 1 | ENSP00000430876.1 | ||||
OPRM1 | ENST00000520282 | c.-261delC | 5_prime_UTR_variant | 1/3 | 1 | ENSP00000430247.1 | ||||
OPRM1 | ENST00000518759.5 | c.47+189delC | intron_variant | 1 | ENSP00000430260.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 30
GnomAD4 exome
Cov.:
30
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: drug response
Submissions summary: Other:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Tramadol response Other:1
drug response, no assertion criteria provided | research | Bruce Budowle Laboratory, University of North Texas Health Science Center | Apr 28, 2018 | - T:M1 = postmortem ratio or tramadol to O-desmethyltramadol; t-MP = model-based clustered metabolizer phenotype inferred from T:M1 |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at